Showing results (711-720 of 2,706) with videos related to
Sort By:
Pageof 271
The Lancet. Infectious Diseases|January 27, 2018
Chlamydia trachomatis and the risk of spontaneous preterm birth, babies who are born small for gestational age, and stillbirth: a population-based cohort studyJoanne Reekie, Christine Roberts, David Preen, et al.The Lancet. Infectious Diseases|January 27, 2018
Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysisMaria Elena Flacco, Lamberto Manzoli, Annalisa Rosso, et al.The Lancet. Infectious Diseases|February 26, 2018
The eyes have it: influenza virus infection beyond the respiratory tractJessica A Belser, R Ryan Lash, Shikha Garg, et al.The Lancet. Infectious Diseases|February 18, 2018
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort studyThe Lancet. Infectious Diseases|February 18, 2018
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort studyGabriella Ferlazzo, Erika Mohr, Chinmay Laxmeshwar, et al.The Lancet. Infectious Diseases|February 20, 2018
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trialMical Paul, George L Daikos, Emanuele Durante-Mangoni, et al.The Lancet. Infectious Diseases|December 5, 2017
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisRavindra K Gupta, John Gregson, Neil Parkin, et al.The Lancet. Infectious Diseases|December 24, 2017
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trialBenoit Guery, Francesco Menichetti, Veli-Jukka Anttila, et al.The Lancet. Infectious Diseases|November 5, 2017
Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic reviewLesley Price, Jennifer MacDonald, Lynn Melone, et al.The Lancet. Infectious Diseases|October 28, 2006
Mother-to-child transmission of HIV-1: timing and implications for preventionAthena P Kourtis, Francis K Lee, Elaine J Abrams, et al.Pageof 271